DOI: http://dx.doi.org/10.18203/2349-2902.isj20204705

A rare extensive clinical presentation of calciphylaxis due to primary hyperparathyroidism

Mohamad Safwan A., K. N. Vijayan, Akash S., Ashwini T., Muhammed Irfan K. P. C.

Abstract


Calciphylaxis is a dreadful condition predominantly seen in chronic kidney disease patients on haemodialysis or following renal transplant. Calciphylaxis occurring in patients with normal kidney function is extremely rare. Here we present 53-year-old women presented with painful, extensive eschar-like skin lesions involving bilateral lower limb of 3 months of duration. She had hypercalcemia, high serum parathyroid hormone (PTH) levels and elevated alkaline phosphatase. Ultrasound neck and sestamibi scan demonstrated left inferior parathyroid adenoma. Lower limb radiographic studies showed subcutaneous calcification. Cutaneous biopsy confirmed calciphylaxis. Cinacalcet to control hypercalcemia, antibiotics and pain control medications were started. Left inferior parathyroidectomy and debridement of gangrenous lesions of lower limbs were performed. Histopathology was consistent with parathyroid adenoma. Lower limb wound started granulating with Vacuum-assisted closure (VAC) dressing and skin graft was planned. Unfortunately, she succumbed 11 weeks from surgery due to proximal myopathy, aspiration pneumonitis, sepsis and multiorgan failure.


Keywords


Calciphylaxis, Vascular calcification, Primary hyperparathyroidism, Parathyroidectomy

Full Text:

PDF

References


Dahl PR, Winkelmann RK, Connolly SM. The vascular calcification-cutaneous necrosis syndrome. J Am Acad Dermatol. 1995;33:53-8.

Nigwekar SU, Kroshinsky D, Nazarian RM, Goverman J, Malhotra R, Jackson VA et al. Calciphylaxis: risk factors, diagnosis, and treatment. Am J Kidney Dis. 2015;66:133-46.

Nigwekar SU, Wolf M, Sterns RH, Hix JK. Calciphylaxis from nonuremic causes: a systematic review. Clin J Am Soc Nephrol. 2008;3:1139-43.

Bishop J, Brown E, Podesta A, Troy C, Dong XE. Surgical management of calciphylaxis associated with primary hyperparathyroidism: a case report and review of the literature. Int J Endocrinol. 2010;2010:823210.

Mirza I, Chaubay D, Gunderia H, Shih W, El-Fanek H. An Unusual Presentation of Calciphylaxis Due to Primary Hyperparathyroidism. Arch Pathol Lab Med. 2001;125(10):1351-3.

Hemdani R, Rajput GR, Sridhar J, Chatterjee M, Rathod D. Calciphylaxis as cutaneous marker of hyperparathyroidism and successful outcome with parathyroidectomy followed by hyperbaric oxygen therapy. Indian J Dermatol Venereol Leprol. 2018;84(2):209-11.

Selye H, Gabbiani G, Strebel R. Sensitization to calciphylaxis by endogenous parathyroid hormone. Endocrinol. 1962;71:554-558.

Bogdonoff MD, Engel FL, White JE, Woods AH: Hyperparathyroidism. Am J Med. 1956;21:583-95.

Khaffif RA, DeLima C, Silverberg A, Frankel R. Calciphylaxis and systemic calcinosis: collective review. Arch Intern Med. 1990;150:956-9.

Ma YL, Cain RL, Halladay DL, Yang X, Zeng Q, Miles RR et al. Catabolic effects of continuous human PTH (1e38) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinol. 2001;142:4047-54.

Klaus W, Richard J, Arturo S. Fitzpatrick's Color Atlas and Synopsis of Clinical Dermatology, 7th ed. McGraw Hill. 2013;429.

Bleyer AJ, Choi M, Igwemezie B, de la Torre E, White WL. A case control study of proximal calciphylaxis. Am J Kidney Dis. 1998;32(3):376-83.

Salmhofer H, Franzen M, Hitzl W, Koller J, Kreymann B, Fend F et al. Multi-modal treatment of calciphylaxis with sodium-thiosulfate, cinacalcet and sevelamer including long-term data. Kidney Blood Press Res. 2013;37:346-359.

Arenas MD, Gil MT, GutiƩrrez MD, Malek T, Moledous A, Salinas A et al. Management of calcific uremic arteriolopathy (calciphylaxis) with a combination of treatments, including hyperbaric oxygen therapy. Clin Nephrol. 2008;70:261-64.